Glycaemic control and hypoglycaemia burden in patients with type 2 diabetes initiating basal insulin in Europe and the USA-Reference-Cited by-同舟云学术

Glycaemic control and hypoglycaemia burden in patients with type 2 diabetes initiating basal insulin in Europe and the USA

Published:2017-04-10 Issue:8 Volume:19 Page:1155-1164
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Mauricio Dídac¹^ORCID,Meneghini Luigi²³,Seufert Jochen⁴,Liao Laura⁵,Wang Hongwei⁵,Tong Liyue⁵,Cali Anna⁶,Stella Peter⁶,Carita Paulo⁶,Khunti Kamlesh⁷

Affiliation:

1. Department of Endocrinology & Nutrition; Hospital Universitari Germans Trias i Pujol, CIBERDEM; Badalona Spain

2. Division of Endocrinology, University of Texas Southwestern Medical Center; Dallas Texas

3. Parkland Health and Hospital System; Dallas Texas

4. Division of Endocrinology and Diabetology, Department of Medicine II, Faculty of Medicine; Medical Center - University of Freiburg; Freiburg Germany

5. Sanofi; Bridgewater New Jersey

6. Sanofi; Paris France

7. Diabetes Research Centre, University of Leicester; Leicester UK

Funder

Sanofi

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.12927/fullpdf

Reference51 articles.

1. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD);Inzucchi;Diabetes Care,2012

2. 10-year follow-up of intensive glucose control in type 2 diabetes;Holman;N Engl J Med,2008

3. National Institute for Health and Clinical Excellence NICE guideline: type 2 diabetes in adults: management 2015 http://www.nice.org.uk/guidance/ng28

4. Working Group of the CPG on type 2 Diabetes 2 Clinical practice guideline for type 2 diabetes [Guía de Práctica Clínica sobre Diabetes tipo 2] 2010 http://www.guiasalud.es/egpc/traduccion/ingles/diabetes/completa/index.html

5. Personalized therapy algorithms for type 2 diabetes: a phenotype-based approach;Ceriello;Pharmgenomics Pers Med,2014

Cited by 104 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Too good to be true: Are GLP-1 receptor agonists the new metformin?;Journal of Diabetes and its Complications;2024-10

2. Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists: Exploring Their Impact on Diabetes, Obesity, and Cardiovascular Health Through a Comprehensive Literature Review;Cureus;2024-09-01

3. Insulin Inertia Among People With Type 2 Diabetes Mellitus in Qatar: The INERT‐Q Study;Endocrinology, Diabetes & Metabolism;2024-06-06

4. Fixed ratio combinations GLP-1RA and basal insulin: literature review;Problems of Endocrinology;2024-02-28

5. Overcoming Therapeutic Inertia in Type 2 Diabetes: Exploring Machine Learning-Based Scenario Simulation for Improving Short-Term Glycemic Control;Machine Learning and Knowledge Extraction;2024-02-14